Research ArticleTheranostics
Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer
Felix Dietlein, Carsten Kobe, Melanie Hohberg, Boris D. Zlatopolskiy, Philipp Krapf, Heike Endepols, Philipp Täger, Jochen Hammes, Axel Heidenreich, Thorsten Persigehl, Bernd Neumaier, Alexander Drzezga and Markus Dietlein
Journal of Nuclear Medicine May 2020, 61 (5) 729-734; DOI: https://doi.org/10.2967/jnumed.119.234898
Felix Dietlein
1Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
Carsten Kobe
1Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
Melanie Hohberg
1Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
Boris D. Zlatopolskiy
3Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital of Cologne, Cologne, Germany
Philipp Krapf
4Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, Jülich, Germany
Heike Endepols
1Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
3Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital of Cologne, Cologne, Germany
Philipp Täger
1Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
Jochen Hammes
1Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
Axel Heidenreich
5Department of Urology, University Hospital of Cologne, Cologne, Germany; and
Thorsten Persigehl
6Institute of Diagnostic and Interventional Radiology, University Hospital of Cologne, Cologne, Germany
Bernd Neumaier
3Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital of Cologne, Cologne, Germany
4Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, Jülich, Germany
Alexander Drzezga
1Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
Markus Dietlein
1Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 5
May 1, 2020
Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer
Felix Dietlein, Carsten Kobe, Melanie Hohberg, Boris D. Zlatopolskiy, Philipp Krapf, Heike Endepols, Philipp Täger, Jochen Hammes, Axel Heidenreich, Thorsten Persigehl, Bernd Neumaier, Alexander Drzezga, Markus Dietlein
Journal of Nuclear Medicine May 2020, 61 (5) 729-734; DOI: 10.2967/jnumed.119.234898
Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer
Felix Dietlein, Carsten Kobe, Melanie Hohberg, Boris D. Zlatopolskiy, Philipp Krapf, Heike Endepols, Philipp Täger, Jochen Hammes, Axel Heidenreich, Thorsten Persigehl, Bernd Neumaier, Alexander Drzezga, Markus Dietlein
Journal of Nuclear Medicine May 2020, 61 (5) 729-734; DOI: 10.2967/jnumed.119.234898
Jump to section
Related Articles
Cited By...
- Unspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
- An 89Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients
- Matched-Pair Comparison of 18F-DCFPyL PET/CT and 18F-PSMA-1007 PET/CT in 240 Prostate Cancer Patients: Interreader Agreement and Lesion Detection Rate of Suspected Lesions